Cargando…
Scheduled injection of ramosetron for prevention of nausea and vomiting following single-port access total laparoscopic hysterectomy: a prospective randomized study
OBJECTIVE: The purpose of this study was to evaluate the effectiveness of scheduled ramosetron injections for controlling postoperative nausea and vomiting (PONV) after single-port access total laparoscopic hysterectomy (SPA-TLH). METHODS: Ninety patients who underwent SPA-TLH at the Korean National...
Autores principales: | Li, Shoou-Chern, Wang, Youngmi, Choi, Seong Jin, Jung, Yeon Soo, Han, Kyoung-Hee, Chung, In Bai, Lee, San-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737055/ https://www.ncbi.nlm.nih.gov/pubmed/31538078 http://dx.doi.org/10.5468/ogs.2019.62.5.344 |
Ejemplares similares
-
The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy
por: Lee, Dong Chul, et al.
Publicado: (2011) -
Ramosetron for the prevention of postoperative nausea and vomiting (PONV): a meta-analysis
por: Kim, Won Oak, et al.
Publicado: (2011) -
Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients
por: Joo, Jin, et al.
Publicado: (2016) -
Comparison of Ramosetron Plus Dexamethasone with Ramosetron Alone on Postoperative Nausea, Vomiting, Shivering and Pain after Thyroid Surgery
por: Lee, Myeong Jong, et al.
Publicado: (2015) -
Stability and Compatibility of Ramosetron with Midazolam in 0.9% Sodium Chloride Injection for Postoperative Nausea and Vomiting Administration
por: Xia, Jingsheng, et al.
Publicado: (2020)